Chubb announced it will offer up to 100 million yuan in clinical trial liability insurance protection on a pro bono basis to qualified domestic medical research and development entities to promote the rapid development of drugs and/or vaccines to fight the outbreak of novel coronavirus (2019-nCoV) first reported from Wuhan, China.
Chubb’s human clinical trial liability insurance provides cover to third parties’ bodily injury caused by any negligence and/or defect in the trial and related activities, such as the protocol, informed consent form, testing drug, or combination drug during the clinical trial process.
Chubb’s pro bono support is targeted to domestic research and development institutions, enterprises and clinical trial centers that have obtained permission to sponsor the human clinical trials to develop the drug to treat new coronavirus infection pneumonia in the territory of People's Republic of China. Human Clinical Trial protocol and informed consent form are required to apply for this insurance product.
Chubb will monitor the development of the antiviral drug and vaccine research and may provide more support in the rapidly developing situation as conditions warrant.
Chubb China has been quickly reacting to the outbreak of the new coronavirus. Customer service quality and employee safety have been prioritized. Emergency plans were activated immediately, together with the launch of a claims response and priority claims policy to clients.
Lear more here.
Learn more here
Chubb Life Vietnam was recently voted among "Vietnam 100 Best places to work 2017" and also ranked in the Top 5 in the insurance sector, according to an independent online survey conducted by Anphabe Career and Intage Vietnam Market Research Company.
This recognition is a testament to Chubb Life Vietnam's talent strategy in the local labor market and also reflects the company's constant efforts towards the highest standards of ethnics, professionalism, client service and productivity.
This year survey was run from November 15,2017 to January 20, 2018,on over 62,000 respondents with at least one year of work experience from 25 occupations accross the country. The evaluation is based on a combination of the factors: wage, bonus and benefits; career development opportunities; corporate culture and values; leadership and management; work-life balance; and corporate reputation.
First run in 2013, this annual survey becomes the most reliable source of information providing latest Talent & EB trends. It is also used as a guideline to consult hundreds of leading enterprises in order to become attractive workplaces and create a professional and happy workforce.